查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2003132

兽用免疫诊断试剂市场：2026-2032年全球市场预测（按产品类型、技术、目标动物、通路、应用和最终用户划分）

Veterinary Immunodiagnostics Market by Product Type, Technology, Animal Type, Distribution Channel, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，兽医免疫诊断市场价值将达到 15.4 亿美元，到 2026 年将成长到 16.7 亿美元，到 2032 年将达到 27.4 亿美元，复合年增长率为 8.51%。

主要市场统计数据
基准年 2025 15.4亿美元
预计年份：2026年 16.7亿美元
预测年份 2032 27.4亿美元
复合年增长率 (%) 8.51%

全面概述了技术创新、临床需求和实际情况如何融合，从而重新定义兽医免疫诊断。

兽医免疫诊断正处于一个转折点，科学进步与不断变化的临床需求在此交汇，重塑着我们检测、管理和预防动物疾病的方式。过去十年，诊断平台已从单一检查室的工作流程转向更整合、自动化和响应迅速的系统，从而能够在各种临床环境中做出及时的临床决策。因此，兽医、诊断检查室和研究机构越来越重视免疫诊断解决方案，不再仅仅将其视为试剂和仪器，而是将其视为更广泛的医疗保健生态系统的组成部分，该生态系统还包括数据分析、照护现场能力和供应链管理。

快速检测创新、工作流程自动化和不断发展的分销模式如何共同重塑兽医免疫诊断的未来。

兽医免疫诊断领域正经历着变革性的转变，这主要得益于技术、临床和商业性趋势的整合。检测方法和检测平台的化学基础的快速发展提高了分析灵敏度和处理能力，从而能够更早、更准确地检测疾病。同时，自动化和整合仪器的兴起减少了人工操作所需的时间和操作误差。这使得诊断服务能够从专业实验室扩展到分散的临床机构。因此，产品设计越来越重视工作流程效率、可重复性和与数位化报告系统的兼容性。

2025 年美国关税措施对营运和采购的影响，以及产业相关人员如何调整其采购和定价策略。

美国2025年实施的关税政策，对兽医免疫诊断供应链的采购、筹资策略和成本结构产生了影响，并引发了一系列新的贸易考量。依赖跨境供应仪器、试剂和检测组件的製造商和经销商被迫重新评估供应商协议、库存政策和供应商多元化策略，以维持服务的连续性。因此，采购团队加快了供应商合格流程，并更加重视多供应商框架，以降低单点故障（SPOF）的风险。

解读产品、技术、目标动物物种、分销、应用和最终用户细分，为优先产品开发和商业化策略提供资讯。

セグメンテーションを详细に理解することで、多様な临床的および运用上のニーズを満たすために、製品开発と商业化の取り组みをどこに集中させるべきかが明らかになります。市场を製品タイプという観点から捉えると、主に3つのカテゴリーが浮かび上がります。それは、免疫检测キット、机器、および试薬です。免疫检测キットには、化学冷光免疫检测キット、ELISAキット、萤光免疫分析法キット、横向流动化验キット、およびラジオ免疫测量キットが含まれ、それぞれがハイスループットな実験室検査から迅速な照护现场筛检に至るまで、异なる使用事例に対応しています。机器には、自动免疫检测システム、化学冷光システム、ルミノメーター、微孔盘リーダーなどが含まれ、处理能力、自动化、分析能力のバランスがそれぞれ异なります。试薬には抗原や抗体に加え、バッファーや溶液などが含まれます。これらはアッセイ性能の基盘となるものであり、一贯した品管が求められます。

美洲、欧洲、中东和非洲以及亚太地区在竞争力和需求方面的区域差异，影响着我们的目标市场策略和产品在地化。

区域趋势指南市场进入和扩大策略提供了独特的机会和营运考虑。在美洲，成熟的检查室网络和强大的私人兽医行业推动了对高性能检测设备和检验的检测试剂盒的需求。这种环境有利于能够提供强大的技术支援、合规性保障以及满足伴侣动物照护和大规模畜牧养殖需求的综合服务模式的供应商。相较之下，欧洲、中东和非洲地区的管理体制和基础设施能力差异很大。在这些地区，市场参与企业必须满足各种不同的合规要求，同时设计出既能适应高度监管市场又能适应检测能力有限地区的解决方案。战略伙伴关係和区域销售协议通常在实现全部区域发挥着至关重要的作用。

产品组合深度、创新速度、策略联盟以及由高价值服务模式驱动的竞争动态决定了市场定位和成长轨迹。

兽医免疫诊断领域的竞争动态融合了成熟跨国诊断公司的优势、高度专业化的创新者的敏捷性以及兽医服务供应商的专业知识。主要企业通常凭藉包含仪器、检验的检测试剂盒和可靠试剂供应的全面产品组合脱颖而出，并投资于品质保证和法规遵从性，以支持临床应用。同时，规模小规模、更灵活的公司则专注于就地检验、新型化学方法或专有的物种特异性诊断，这通常使它们能够更快地检验创新方法并满足特定应用需求。

为加速在各种兽医环境中采用技术、加强供应链、协调检验流程和扩大商业性覆盖范围，提出切实可行的策略建议。

在瞬息万变的环境中，产业领导企业应推动一系列切实可行的倡议，以创造价值并降低营运风险。首先，应优先投资于兼顾分析性能和工作流程效率的检测平台和仪器，确保产品能够满足集中式检查室和分散式临床环境的需求。这将透过使检验策略与监管预期和最终用户使用案例保持一致，加速临床应用和产品整合到治疗流程中。其次，应透过供应商多元化、区域製造伙伴关係以及健全的品质系统来增强供应链韧性，从而减轻贸易中断的影响，并维持试剂的稳定供应。

采用透明、多方面的研究途径，结合专家直接参与、检查室验证审查和系统性的次要分析，以确保获得可靠的见解。

本分析采用透明、多面向的研究方法整合证据，旨在确保其相关性和严谨性。主要调查包括对检查室管理人员、兽医、采购负责人和行业高管进行结构化访谈，以了解实际操作、验证预期和采购决定因素。从这些定性对话中获得的见解有助于解读技术采纳模式以及影响最终用户选择的实际限制。次要调查包括对科学文献、监管指南和产品文件进行系统性回顾，以检验检测特性并确定每项技术的方法学优势和局限性。

本文概述了综合诊断创新、营运韧性和商业性可行性将如何决定兽医免疫诊断领域未来的成功。

総括すると、獣医免疫诊断分野では、技术革新と実用的な运用戦略を结びつけた统合的な対応が求められます。诊断开発者は、分析的な卓越性を达成するだけでなく、检查室や诊疗所のワークフローに适合し、种特有のニーズに対応し、地域の规制要件を満たす製品を设计しなければなりません。サプライヤーの多様化や地域に特化した製造アプローチを含む运用上のレジリエンスは、検査の継続性を维持し、集体爆发时の迅速な対応を支えるために不可欠です。商业性的な成功は、信頼性の高い供给、有意义なアフターサービス、そして临床的效用を高めるデジタルツールを通じて、付加価値を提供できるかどうかにかかっています。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 兽用免疫诊断试剂市场：依产品类型划分

  • 免疫检测盒
    • 化学冷光免疫检测试剂盒
    • ELISA（酵素免疫分析法）试剂盒
    • 萤光免疫分析法盒
    • 横向流动化验试剂盒
    • 免疫测量（RIA）试剂盒
  • 装置
    • 自动化免疫检测系统
    • 化学冷光系统
    • 光度计
    • 微孔盘读数仪
  • 试剂
    • 抗原/抗体
    • 缓衝液/溶液

第九章 兽用免疫诊断试剂市场：依技术划分

  • 化学冷光免疫检测
  • ELISA
  • 流式细胞技术
  • 萤光免疫分析
  • 免疫组织化学（IHC）
  • 侧向流动免疫检测
  • 免疫测量（RIA）
  • 蛋白质印迹法

第十章 兽用免疫诊断市场：依动物类型划分

  • 水生动物
  • 伴侣动物
    • 狗
    • 猫
  • 家畜
    • 牛
    • 山羊
    • 家禽
    • 猪

第十一章 兽用免疫诊断试剂市场：依通路划分

  • 离线
  • 在线的

第十二章 兽用免疫诊断试剂市场：依应用领域划分

  • 自体免疫疾病的诊断
  • 癌症诊断
  • 食品安全与品质检验
  • 荷尔蒙和代谢紊乱的诊断
  • 感染疾病诊断
  • 妊娠和生育能力测试
  • 毒素检测

第十三章 兽用免疫诊断试剂市场：依最终用户划分

  • 诊断检测实验室
  • 製药和生物技术公司
  • 研究机构
  • 兽医医院和兽医诊所

第十四章 兽用免疫诊断试药市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 兽用免疫诊断试剂市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 兽用免疫诊断试剂市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国兽用免疫诊断市场

第十八章：中国兽用免疫诊断剂市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Agrolabo SpA
  • Bio-Rad Laboratories, Inc.
  • BioChek BV
  • Biogal Galed Labs
  • bioMerieux SA
  • Bionote USA Inc.
  • Biopanda Reagents Ltd.
  • EIKEN CHEMICAL CO.,LTD
  • Elanco Animal Health
  • FUJIFILM Holdings Corporation
  • GD Animal Health
  • Heska Corporation
  • IDEXX Laboratories, Inc.
  • INDICAL BIOSCIENCE GmbH
  • Innovative Diagnostics SAS
  • LABOKLIN GMBH & CO. KG
  • Neogen Corporation
  • QIAGEN NV
  • Randox Laboratories Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Thermo Fisher Scientific Inc.
  • URIT Medical Electronic Co., Ltd.
  • Virbac Animal Health India Pvt. Ltd
  • VolitionRx Limited
  • Zoetis Inc.
Product Code: MRR-AD517FAA8B82

The Veterinary Immunodiagnostics Market was valued at USD 1.54 billion in 2025 and is projected to grow to USD 1.67 billion in 2026, with a CAGR of 8.51%, reaching USD 2.74 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.54 billion
Estimated Year [2026] USD 1.67 billion
Forecast Year [2032] USD 2.74 billion
CAGR (%) 8.51%

A comprehensive orientation to how technological innovation, clinical demand, and operational realities are converging to redefine veterinary immunodiagnostics

Veterinary immunodiagnostics stands at an inflection point where scientific advances and evolving clinical needs converge to reshape how diseases in animals are detected, managed, and prevented. Over the past decade, diagnostic platforms have moved from bespoke laboratory workflows toward more integrated, automated, and rapid-response systems that enable timely clinical decision-making across diverse care settings. As a result, veterinary practitioners, diagnostic laboratories, and research organizations increasingly consider immunodiagnostic solutions not merely as reagents and instruments but as components of broader health management ecosystems that include data analytics, point-of-care capabilities, and supply chain considerations.

This dynamic environment places a premium on adaptability. Stakeholders must reconcile the dual imperatives of technological innovation and operational reliability while navigating shifting regulatory frameworks and procurement practices. Therefore, executives need a clear line of sight into the prevailing diagnostic modalities, product form factors, and the end-user requirements that govern adoption. In addition, supply chain resilience, reagent quality, and interoperability with laboratory information systems have become decisive factors in purchasing decisions. Taken together, these forces necessitate a strategic approach that balances scientific rigor, commercial feasibility, and service delivery models to ensure diagnostic solutions meet the growing complexity of veterinary care.

How rapid assay innovation, workflow automation, and evolving distribution models are jointly reshaping the future of veterinary immunodiagnostics

The landscape of veterinary immunodiagnostics is undergoing transformative shifts driven by converging technological, clinical, and commercial trends. Rapid advances in assay chemistries and detection platforms have improved analytical sensitivity and throughput, enabling earlier and more accurate disease detection. At the same time, the rise of automation and integrated instrumentation has reduced hands-on time and variability, which in turn supports scaling diagnostic services from specialized labs to decentralized clinical settings. Consequently, product design is increasingly guided by the need for workflow efficiency, reproducibility, and compatibility with digital reporting systems.

Parallel to technological gains, clinical demand is expanding in scope and complexity. Practitioners across companion and livestock animal care settings require diagnostics that support preventive health, outbreak response, and food safety assurance. This shift places a premium on multiplexing capability and rapid turnaround, which allow veterinarians and producers to make evidence-based interventions. Moreover, regulatory landscapes and quality assurance expectations are maturing, prompting manufacturers to invest in validation, documentation, and post-market surveillance strategies that demonstrate clinical utility and reliability.

Commercial models are also evolving. Distribution channels now blend traditional offline relationships with growing online procurement pathways that emphasize convenience and quicker replenishment cycles. Strategic partnerships between diagnostics firms, pharmaceutical companies, and laboratory networks are intensifying, as firms seek to combine product portfolios with service delivery to capture greater value. Taken together, these transformative shifts underscore the need for integrated strategies that align product innovation with regulatory compliance, clinical applicability, and scalable distribution.

Operational and procurement consequences of United States tariff measures in 2025 and how industry participants are adapting sourcing and pricing strategies

United States tariff policies implemented in 2025 have introduced a recalibrated set of trade considerations that affect procurement, sourcing strategies, and cost structures within the veterinary immunodiagnostics supply chain. Manufacturers and distributors that rely on cross-border supply of instruments, reagents, and assay components have had to reassess vendor contracts, inventory policies, and supplier diversification to preserve continuity of service. As a result, procurement teams have accelerated supplier qualification processes and increased emphasis on multi-source frameworks to mitigate the risk of single points of failure.

In addition, the tariff environment has sharpened attention toward localized production capabilities and regional manufacturing partnerships. Stakeholders have responded by exploring nearshoring and dual-sourcing tactics that reduce exposure to import levies while preserving access to critical raw materials and specialized components. This operational realignment often requires upfront investments in supplier development and quality systems to ensure that alternative sources meet the validation standards required for diagnostic use. Furthermore, distributors and clinical end users have refined inventory management practices to buffer against episodic supply interruptions, with greater reliance on safety stock and predictive replenishment linked to clinical demand signals.

Importantly, the tariff-driven adjustments have also influenced strategic pricing and contracting approaches. Commercial teams are increasingly negotiating longer-term agreements that include clauses for duty mitigation and supply continuity, and manufacturers are exploring value-added service bundles to justify any price adjustments. Collectively, these responses reflect an industry-wide effort to maintain clinical access to essential immunodiagnostic tools while navigating the practical implications of updated trade measures.

Decoding product, technology, species, distribution, application, and end-user segmentation to inform prioritized product development and commercialization strategies

A nuanced understanding of segmentation reveals where product development and commercial efforts should concentrate to meet diverse clinical and operational needs. When the market is viewed through the lens of product type, three primary categories emerge: Immunoassay Kits, Instruments, and Reagents. Immunoassay Kits span chemiluminescent immunoassay kits, ELISA kits, fluorescence immunoassay kits, lateral flow assay kits, and radioimmunoassay kits, each addressing distinct use cases ranging from high-throughput laboratory testing to rapid point-of-care screening. Instruments include automated immunoassay systems, chemiluminescence systems, luminometers, and microplate readers, offering different balances of throughput, automation, and analytical capability. Reagents cover antigens and antibodies as well as buffers and solutions, which are foundational to assay performance and require consistent quality control.

Looking at technology, the market encompasses chemiluminescence immunoassays, ELISA, flow cytometry, fluorescence immunoassays, immunohistochemistry, lateral flow immunoassays, radioimmunoassay, and Western blotting. Each technology presents distinct strengths: some excel in sensitivity and quantitative output, while others offer rapid, equipment-free deployment suitable for field use. These technological distinctions drive decisions around validation pathways, end-user training, and laboratory integration.

Animal type introductions further refine product priorities. Aquatic animals, companion animals, and livestock animals exhibit different epidemiological profiles and testing requirements. Companion animal diagnostics often prioritize canine and feline applications with a focus on individualized care and preventive screening. Conversely, livestock diagnostics must support cattle, goats, poultry, and swine sectors where herd-level surveillance, rapid outbreak detection, and food safety implications shape product expectations.

Distribution channels bifurcate into offline and online pathways, and each route demands distinct service models. Offline channels traditionally emphasize field sales, technical support, and long-term supply relationships, whereas online procurement accelerates reorder cycles and supports standardized purchasing for institutional buyers. Applications span autoimmune disease diagnostics, cancer diagnostics, food safety and quality testing, hormonal and metabolic disorder diagnostics, infectious disease diagnostics, pregnancy and fertility testing, and toxin detection. These use cases dictate assay design, regulatory requirements, and clinical validation endpoints. Finally, end users include diagnostic laboratories, pharmaceutical and biotechnology companies, research institutes, and veterinary clinics and hospitals, each bringing unique operational constraints and procurement criteria that must be addressed through tailored product features and service offerings.

Taken together, segmentation insights highlight the importance of aligned product portfolios, validation strategies, and channel approaches that reflect the varied demands across technologies, animal types, and end-use contexts.

Regional competitiveness and differentiated demand across the Americas, Europe Middle East & Africa, and Asia-Pacific that shape targeted market strategies and product localization

Regional dynamics present differentiated opportunities and operational considerations that should guide market entry and expansion strategies. In the Americas, well-established laboratory networks and a strong private veterinary sector drive demand for high-performance laboratory instruments and validated assay kits. This environment favors suppliers that offer robust technical support, regulatory alignment, and integrated service models that address both companion animal practices and large-scale livestock operations. In contrast, Europe, Middle East & Africa encompasses a wide spectrum of regulatory regimes and infrastructure capabilities. Here, market participants must navigate varied compliance requirements while designing solutions that are adaptable to both highly regulated markets and regions where laboratory capacity may be more limited. Strategic partnerships and regional distribution agreements often play a decisive role in achieving traction across this diverse geography.

Asia-Pacific presents a complex mix of rapid adoption and infrastructure heterogeneity. Several countries in the region have expanded veterinary services and food safety programs, creating demand for scalable diagnostics across both companion and livestock sectors. At the same time, local manufacturing capabilities and cost sensitivities influence procurement decisions, prompting multinational firms to consider manufacturing partnerships, licensing arrangements, and tailored product versions that meet regional price-performance expectations. Shifts in animal production systems, intensification of aquaculture, and heightened regulatory focus on feed and food safety further influence product priorities in this region. Across all geographies, logistics, regulatory harmonization efforts, and local technical support capabilities remain pivotal factors in determining successful deployment and sustained adoption.

Competitive landscape dynamics driven by portfolio depth, innovation velocity, strategic alliances, and value-added service models that determine market positioning and growth pathways

Competitive dynamics in veterinary immunodiagnostics combine the strengths of established multinational diagnostics firms with the agility of specialized innovators and the domain expertise of veterinary service providers. Leading organizations typically differentiate through comprehensive portfolios that pair instruments with validated assay kits and reliable reagent supplies, and they invest in quality assurance and regulatory compliance to support clinical adoption. In parallel, smaller, nimble companies specialize in point-of-care assays, novel chemistries, or unique species-specific diagnostics, often moving more quickly to validate innovative modalities and to serve niche applications.

Collaboration models are increasingly common. Commercial partnerships between instrument manufacturers and reagent suppliers create bundled solutions that reduce integration friction for laboratory and clinical buyers. Likewise, alliances with local distributors or service providers extend technical support capabilities into regions with diverse infrastructure. Competitive positioning also hinges on post-sale service, training, and digital tools that streamline result interpretation and reporting. These value-added services frequently determine adoption in markets where technical capacity varies. Lastly, firms that align product design with end-user workflows and regulatory requirements secure stronger uptake, as ease of use and confidence in analytical performance are central to purchasing decisions across both companion and production animal markets.

Practical strategic recommendations to fortify supply chains, align validation pathways, and expand commercial reach while accelerating technology adoption across diverse veterinary settings

Industry leaders should pursue a set of pragmatic actions to capture value and mitigate operational risk in a rapidly changing environment. First, prioritize investment in assay platforms and instrumentation that balance analytical performance with workflow efficiency, ensuring that products meet the needs of both centralized laboratories and decentralized clinical settings. To that end, aligning validation strategies with regulatory expectations and end-user use cases will accelerate clinical acceptance and integration into care pathways. Second, reinforce supply chain resilience through supplier diversification, regional manufacturing partnerships, and robust quality systems to reduce exposure to trade-related disruptions and to maintain steady reagent availability.

Third, expand commercial models to blend offline technical engagement with online procurement conveniences, thereby catering to institutional buyers and smaller clinical practices simultaneously. Complementary to distribution adaptations, cultivate strategic partnerships with laboratory networks, animal health services, and research organizations to co-develop applications and to validate clinical utility in real-world settings. Fourth, invest in digital tools and data analytics that enhance assay interpretation, facilitate surveillance, and enable predictive replenishment. Such digital capabilities not only improve clinical decision-making but also create recurring value streams that strengthen customer relationships.

Finally, adopt a regionally adaptive strategy that balances global standards with local customization. This includes tailoring product offerings to meet regional regulatory frameworks, cost sensitivities, and infrastructure realities. By implementing these actions in a coordinated manner, industry players can strengthen market resilience, accelerate adoption of advanced diagnostics, and better support animal health outcomes across species and geographies.

Transparent, multi-method research approach combining primary expert engagement, laboratory validation review, and systematic secondary analysis to ensure robust insights

This analysis synthesizes evidence through a transparent, multi-method research approach designed to ensure relevance and rigor. Primary research included structured interviews with laboratory directors, veterinary clinicians, procurement professionals, and industry executives to capture operational realities, validation expectations, and procurement drivers. These qualitative engagements informed the interpretation of technology adoption patterns and the practical constraints that shape end-user choices. Secondary research involved a systematic review of scientific literature, regulatory guidance, and product documentation to validate assay characteristics and to understand methodological strengths and limitations across technologies.

Where feasible, laboratory-level validation studies and technical performance data were reviewed to corroborate claims regarding sensitivity, specificity, and workflow integration. Supply chain assessments drew upon publicly available trade data and industry disclosures to identify key sourcing dependencies and logistical constraints. Throughout the process, findings were triangulated across multiple sources to mitigate bias and to ensure that conclusions reflect both scientific evidence and market realities. Methodological transparency and source traceability undergird the analysis, enabling stakeholders to evaluate the applicability of insights to their specific organizational contexts.

Concluding synthesis of how integrated diagnostic innovation, operational resilience, and commercial execution together determine future success in veterinary immunodiagnostics

In synthesis, veterinary immunodiagnostics requires an integrated response that couples technological innovation with practical operational strategies. Diagnostic developers must design products that not only achieve analytical excellence but also fit into the workflows of laboratories and clinics, accommodate species-specific needs, and meet regional regulatory expectations. Operational resilience, including supplier diversification and targeted regional manufacturing approaches, is essential to preserve continuity of testing and to support rapid response in outbreak scenarios. Commercial success will hinge on the ability to offer bundled value through reliable supply, meaningful post-sale service, and digital tools that enhance clinical utility.

Looking forward, stakeholders that align product development with real-world use cases, invest in robust validation and quality systems, and adopt adaptive distribution models will be best positioned to support animal health outcomes across companion, production, and aquatic sectors. By synthesizing the technological, regulatory, and commercial dimensions of the market, organizations can craft strategies that deliver both clinical impact and sustainable commercial returns.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Veterinary Immunodiagnostics Market, by Product Type

  • 8.1. Immunoassay Kits
    • 8.1.1. Chemiluminescent Immunoassay Kits
    • 8.1.2. ELISA (Enzyme-Linked Immunosorbent Assay) Kits
    • 8.1.3. Fluorescence Immunoassay Kits
    • 8.1.4. Lateral Flow Assay Kits
    • 8.1.5. Radioimmunoassay (RIA) Kits
  • 8.2. Instruments
    • 8.2.1. Automated Immunoassay Systems
    • 8.2.2. Chemiluminescence Systems
    • 8.2.3. Luminometers
    • 8.2.4. Microplate Readers
  • 8.3. Reagents
    • 8.3.1. Antigens & Antibodies
    • 8.3.2. Buffers & Solutions

9. Veterinary Immunodiagnostics Market, by Technology

  • 9.1. Chemiluminescence Immunoassays
  • 9.2. ELISA
  • 9.3. Flow Cytometry
  • 9.4. Fluorescence Immunoassays
  • 9.5. Immunohistochemistry (IHC)
  • 9.6. Lateral Flow Immunoassays
  • 9.7. Radioimmunoassay (RIA)
  • 9.8. Western Blotting

10. Veterinary Immunodiagnostics Market, by Animal Type

  • 10.1. Aquatic Animals
  • 10.2. Companion Animals
    • 10.2.1. Canine
    • 10.2.2. Feline
  • 10.3. Livestock Animals
    • 10.3.1. Cattle
    • 10.3.2. Goats
    • 10.3.3. Poultry
    • 10.3.4. Swine

11. Veterinary Immunodiagnostics Market, by Distribution Channel

  • 11.1. Offline
  • 11.2. Online

12. Veterinary Immunodiagnostics Market, by Application

  • 12.1. Autoimmune Disease Diagnostics
  • 12.2. Cancer Diagnostics
  • 12.3. Food Safety & Quality Testing
  • 12.4. Hormonal & Metabolic Disorder Diagnostics
  • 12.5. Infectious Disease Diagnostics
  • 12.6. Pregnancy & Fertility Testing
  • 12.7. Toxin Detection

13. Veterinary Immunodiagnostics Market, by End User

  • 13.1. Diagnostic Laboratories
  • 13.2. Pharmaceutical & Biotechnology Companies
  • 13.3. Research Institutes
  • 13.4. Veterinary Clinics & Hospitals

14. Veterinary Immunodiagnostics Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Veterinary Immunodiagnostics Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Veterinary Immunodiagnostics Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Veterinary Immunodiagnostics Market

18. China Veterinary Immunodiagnostics Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Agrolabo S.p.A.
  • 19.6. Bio-Rad Laboratories, Inc.
  • 19.7. BioChek BV
  • 19.8. Biogal Galed Labs
  • 19.9. bioMerieux SA
  • 19.10. Bionote USA Inc.
  • 19.11. Biopanda Reagents Ltd.
  • 19.12. EIKEN CHEMICAL CO.,LTD
  • 19.13. Elanco Animal Health
  • 19.14. FUJIFILM Holdings Corporation
  • 19.15. GD Animal Health
  • 19.16. Heska Corporation
  • 19.17. IDEXX Laboratories, Inc.
  • 19.18. INDICAL BIOSCIENCE GmbH
  • 19.19. Innovative Diagnostics SAS
  • 19.20. LABOKLIN GMBH & CO. KG
  • 19.21. Neogen Corporation
  • 19.22. QIAGEN N.V.
  • 19.23. Randox Laboratories Ltd.
  • 19.24. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 19.25. Thermo Fisher Scientific Inc.
  • 19.26. URIT Medical Electronic Co., Ltd.
  • 19.27. Virbac Animal Health India Pvt. Ltd
  • 19.28. VolitionRx Limited
  • 19.29. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ELISA (ENZYME-LINKED IMMUNOSORBENT ASSAY) KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ELISA (ENZYME-LINKED IMMUNOSORBENT ASSAY) KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ELISA (ENZYME-LINKED IMMUNOSORBENT ASSAY) KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAY KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAY KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA) KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA) KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA) KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AUTOMATED IMMUNOASSAY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AUTOMATED IMMUNOASSAY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AUTOMATED IMMUNOASSAY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LUMINOMETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LUMINOMETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LUMINOMETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY MICROPLATE READERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY MICROPLATE READERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY MICROPLATE READERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANTIGENS & ANTIBODIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANTIGENS & ANTIBODIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANTIGENS & ANTIBODIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY BUFFERS & SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY BUFFERS & SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY BUFFERS & SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ELISA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY (IHC), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY (IHC), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY (IHC), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LATERAL FLOW IMMUNOASSAYS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LATERAL FLOW IMMUNOASSAYS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LATERAL FLOW IMMUNOASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY WESTERN BLOTTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY WESTERN BLOTTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY WESTERN BLOTTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AQUATIC ANIMALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AQUATIC ANIMALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AQUATIC ANIMALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CANINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CANINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CANINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FELINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FELINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FELINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CATTLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CATTLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY GOATS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY GOATS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY GOATS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY POULTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY POULTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY SWINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY SWINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASE DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASE DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASE DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CANCER DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CANCER DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FOOD SAFETY & QUALITY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FOOD SAFETY & QUALITY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FOOD SAFETY & QUALITY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY HORMONAL & METABOLIC DISORDER DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY HORMONAL & METABOLIC DISORDER DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY HORMONAL & METABOLIC DISORDER DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TOXIN DETECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TOXIN DETECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TOXIN DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY VETERINARY CLINICS & HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY VETERINARY CLINICS & HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY VETERINARY CLINICS & HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 147. AMERICAS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. AMERICAS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, 2018-2032 (USD MILLION)
  • TABLE 149. AMERICAS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 150. AMERICAS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 151. AMERICAS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 152. AMERICAS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. AMERICAS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 154. AMERICAS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 155. AMERICAS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 156. AMERICAS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. AMERICAS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. GCC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. GCC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. GCC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, 2018-2032 (USD MILLION)
  • TABLE 258. GCC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 259. GCC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 260. GCC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 261. GCC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 262. GCC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 263. GCC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 264. GCC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 265. GCC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 266. GCC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPEAN UNION VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 279. BRICS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 280. BRICS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. BRICS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, 2018-2032 (USD MILLION)
  • TABLE 282. BRICS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 283. BRICS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 284. BRICS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 291. G7 VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 292. G7 VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 293. G7 VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, 2018-2032 (USD MILLION)
  • TABLE 294. G7 VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 295. G7 VETERINARY IMMUNO